The DIG System Nonradioactive Automated,,,High-Throughput In Situ Hybridization:,,,a Powerful Tool for Functional Genomics Research
arvae or tiny plant root tips instruments optimized forwhole-mount in situ hybridization (e.g. Intavis) are suitable.However the large majority of tissues are too largefor the whole-mount method and have to be dissectedsectioned and attached to microscope slides for furtheranalysis. The Max Planck Institute of Experimental Endocrinology
arvae, or tiny plant root tips, instruments optimized for
whole-mount in situ hybridization (e.g., Intavis) are suitable.
However, the large majority of tissues are too large
for the whole-mount method and have to be dissected,
sectioned, and attached to microscope slides for further
analysis.
The Max Planck Institute of Experimental Endocrinology
in Hanover and the Swiss lab automation company
Tecan have jointly developed a new system to process
microscope slides with tissue sections. The slides carrying
tissue sections are assembled into flow-through
chambers and remain there until the end of the procedure.
Capillary forces ensure that the tissue sections are
liquid-covered at all times and protected from damage and desiccation. All solutions are added to the chambers
by the computer-controlled liquid-handling system
and displace the solution of the previous incubation. The
instrument accommodates two thermoracks for the
simultaneous processing of 96 slides.
The results described in this report have been generated
by the group of Professor Gregor Eichele, Hanover.
Examples presented are the expression of calbindin in
the adult mouse brain and of neurotrophic tyrosine
kinase type 2 receptor (Ntrk2) in a 14.5-day-old mouse
embryo. More results of the groups large-scale mouse
gene expression project can be viewed at www.genepaint.
org. The nonradioactive automated in situ
hybridization method and its application have been
described previously [1, 2, 3].
Materials and Methods
Preparation of DIG-labeled RNA probe
The DNA template corresponding to the gene of interest
is produced by polymerase chain reaction (PCR) using a
gene-specific primer pair that also comprises the T3, T7,
or SP6 promoter sequences.
'"/>Source:
Page: All 1 2 3 4 5 6 Related biology technology :1.
New Mammalian Two-Hybrid System Detects Protein-Protein Interactions2.
Assess the In Vivo Activation of Signal Transduction Pathways with
PathDetect Reporting Systems3.
Generate Adenovirus Vectors in E. coli by Homologous Recombination
with the AdEasy Adenoviral Vector System4.
New Yeast Cloning System for Producing Proteins with Native Amino Acid
Sequences5.
Enhanced PCR Cloning System6.
prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification7.
Performance Comparisons of Commercial RT-PCR Systems8.
Signal Transduction Reporting Systems Using Cis-Acting Enhancer
Elements9.
Yeast Protein Production System Features High Yields and One-Step
Purification10.
Detect Released Oligosaccharides Using the Eagle Eye II
Still Video Imaging System11.
Identification of Differentially Expressed Gene Products with the CastAway
System*
(Date:11/5/2009)... Drug safety specialty firm BioSoteria an...nformatics earned the Certified Professional in Le...om the American Society for Training and Developme...ll has more than fifteen years of medical communic...responsible for the development of the company,s o...
(Date:11/4/2009)... This webinar, which will be presented on...in continuous flow chemistry processing, will deal...ine using various meso and micro scale flow chemis...ublications has been recognized with several prest...the 2009 Tetrahedron Prize. , ...
(Date:11/4/2009)..., Va., Nov. 4 Star Sci...hat the company plans to introduce the CigRx(TM) n...Rock Creek Pharmaceuticals, for worldwide marketin... Inc . (Nasdaq: VTIV). inVentiv Health offers a ...every stage of the product lifecycle, in a range o...
(Date:11/4/2009)..., Calif., Nov. 4 Nektar ...inancial results for the third quarter ended Septe...ed September 30, 2009 improved to $31.0 million or....0 million or $0.40 per share in the third quarter...ements to its operating efficiencies as compared t...
Breaking Biology Technology:BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10... MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ...and commercializing novel anti-infective products,...al recruiting firm TalenTactics,LLC to lead its fi...pany,s,MOXATAG(TM) (amoxicillin extended-release t...the first half of 2009., MiddleBrook President an...
...ncreased 4% for the 2008 Third Quarter and ... Quarter Revenue Growth in Pharmaceuticals Divisio...ritionals +18% and Prevnar +13% , - Guidance...gnificant Items, Revised to a Range of $3...creased by 7.1% MADISON, N.J., Oct. 22 Wyeth (NY...
...ed at 20th EORTC-NCI-AACR Symposium -, SOUTH SAN ...FirstCall/,-- Poniard Pharmaceuticals, Inc. (Nasda... oncology, today announced positive incremental da...platin in combination with,docetaxel and prednison...ractory prostate cancer (HRPC). The expanded and u...
Other Biology Technology:MiddleBrook Hires TalenTactics to Recruit National Field Force 2MiddleBrook Hires TalenTactics to Recruit National Field Force 3Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 2Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 3Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 4Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 5Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 6Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 7Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 8Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 9Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 10Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 11Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 12Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 13Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 14Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer 2Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer 3Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer 4Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer 5(Date:11/4/2009)...avy traffic corridors in the cities of Long Beach ...oportion of preventable childhood asthma, and the ... the disease has likely been underestimated, accor...California (USC). , The study, which appears in...lic Health , estimated that nine percent of all ch...
(Date:11/4/2009)...e University of Oklahoma at Norman has received mo...unding agencies as part of the federal stimulus pr...g received by OU researchers to $23 million. Thir...earch ranging from archaeology to weather. , "Th...tic approach to matching areasof scholarly excelle...
(Date:11/4/2009)..., BEDFORD, Mass., Oct. 20 /PRNewswire-FirstCall/ -... of broadband technology and biometrics software, ...arter ended September 30, 2009. ,, Michael Tz...r, said, "Earlier today, we announced an agreement... to Lantiq, a new fabless semiconductor company be...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Childrens Hospital Boston eClinicalWorks Team to Push Clinical Information Into Patients Personally Controlled Health Records 57031 1Childrens Hospital Boston eClinicalWorks Team to Push Clinical Information Into Patients Personally Controlled Health Records 57031 2Childrens Hospital Boston eClinicalWorks Team to Push Clinical Information Into Patients Personally Controlled Health Records 57031 3Childrens Hospital Boston eClinicalWorks Team to Push Clinical Information Into Patients Personally Controlled Health Records 57031 4Childrens Hospital Boston eClinicalWorks Team to Push Clinical Information Into Patients Personally Controlled Health Records 57031 5Fountain Healthy Aging Inc Announces Agreement to Acquire Natural Planet USA 14018 1Fountain Healthy Aging Inc Announces Agreement to Acquire Natural Planet USA 14018 2Fountain Healthy Aging Inc Announces Agreement to Acquire Natural Planet USA 14018 3Cadient Group Ranks on Inc 5000 List of Fastest Growing Companies for Third Consecutive Year 14016 1Cadient Group Ranks on Inc 5000 List of Fastest Growing Companies for Third Consecutive Year 14016 2Mouse Anti-Vesicular Glutamate Transporter 2 (VGLUT2) Antibody, Unconjugated from CHEMICON
Proteinase K Buffer from BD Biosciences Pharmingen
RNase Buffer from BD Biosciences Pharmingen
Mouse cAMP / Ca2+ Signaling PathwayFinder, PCR Array for expression profiling from SuperArray Bioscience
Biology Products: